Yakult UK Ltd will be attending BDA Live and exhibiting in the Cambridge Suite.
Science has remained firmly at the core of the Yakult company since the unique Lactobacillus casei Shirota strain was isolated back in 1930. In the field of probiotics, Yakult has a long history of safe use and an unparalleled reputation for quality and research. To date, over 100 peer-reviewed publications describe human studies with Yakult’s Lactobacillus casei Shirota strain, in a wide range of health areas including antibiotic-associated diarrhoea, infectious disease, constipation, IBS, sports and cancer. For more information, visit the dedicated healthcare professional site www.yakult.co.uk/hcp or contact the UK Science Team on 020 8842 7600 or email@example.com for free healthcare literature and resources.